{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:30:43Z","timestamp":1786689043060,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Health Research Project","award":["TJWJ2022XK039"],"award-info":[{"award-number":["TJWJ2022XK039"]}]},{"name":"Natural Science Foundation of Tianjin Municipal Science and Technology Bureau","award":["22JCZDJC00110"],"award-info":[{"award-number":["22JCZDJC00110"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-08177-9","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:05:54Z","timestamp":1781078754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between serum non-enzymatic antioxidants and cognitive impairment in drug-na\u00efve patients with schizophrenia"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhenning","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaimina","family":"Xuekelaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"7321","key":"8177_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature09552","volume":"468","author":"TR Insel","year":"2010","unstructured":"Insel TR. Rethinking schizophrenia. Nature. 2010;468(7321):187\u201393.","journal-title":"Nature"},{"issue":"3","key":"8177_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S2215-0366(18)30511-X","volume":"6","author":"Y Huang","year":"2019","unstructured":"Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J, Yu Y, Kou C, Xu X, Lu J, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. lancet Psychiatry. 2019;6(3):211\u201324.","journal-title":"lancet Psychiatry"},{"key":"8177_CR3","doi-asserted-by":"crossref","unstructured":"Kadakia A, Catillon M, Fan Q, Williams GR, Marden JR, Anderson A, Kirson N, Dembek C. The Economic Burden of Schizophrenia in the United States. J Clin Psychiatry 2022, 83(6).","DOI":"10.4088\/JCP.22m14458"},{"issue":"1","key":"8177_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/wps.20194","volume":"14","author":"RB Zipursky","year":"2015","unstructured":"Zipursky RB, Agid O. Recovery, not progressive deterioration, should be the expectation in schizophrenia. World psychiatry: official J World Psychiatric Association (WPA). 2015;14(1):94\u20136.","journal-title":"World psychiatry: official J World Psychiatric Association (WPA)"},{"issue":"21\u201322","key":"8177_CR5","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1007\/s00213-015-3960-8","volume":"232","author":"J Lees","year":"2015","unstructured":"Lees J, Applegate E, Emsley R, Lewis S, Michalopoulou P, Collier T, Lopez-Lopez C, Kapur S, Pandina GJ, Drake RJ. Calibration and cross-validation of MCCB and CogState in schizophrenia. Psychopharmacology. 2015;232(21\u201322):3873\u201382.","journal-title":"Psychopharmacology"},{"issue":"1","key":"8177_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/schbul\/sbp094","volume":"36","author":"E Bora","year":"2010","unstructured":"Bora E, Y\u00fccel M, Pantelis C. Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond. Schizophr Bull. 2010;36(1):36\u201342.","journal-title":"Schizophr Bull"},{"issue":"7","key":"8177_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/15622975.2021.2013093","volume":"23","author":"DM Wang","year":"2022","unstructured":"Wang DM, Du YX, Zhu RR, Tian Y, Chen JJ, Chen DC, Wang L, Zhang XY. The relationship between cognitive impairment and superoxide dismutase activity in untreated first-episode patients with schizophrenia. world J Biol psychiatry: official J World Federation Soc Biol Psychiatry. 2022;23(7):517\u201324.","journal-title":"world J Biol psychiatry: official J World Federation Soc Biol Psychiatry"},{"issue":"2","key":"8177_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/wps.20650","volume":"18","author":"P Falkai","year":"2019","unstructured":"Falkai P, Schmitt A. The need to develop personalized interventions to improve cognition in schizophrenia. World psychiatry: official J World Psychiatric Association (WPA). 2019;18(2):170.","journal-title":"World psychiatry: official J World Psychiatric Association (WPA)"},{"issue":"3","key":"8177_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.biopsych.2019.09.021","volume":"87","author":"AJ Robison","year":"2020","unstructured":"Robison AJ, Thakkar KN, Diwadkar VA. Cognition and Reward Circuits in Schizophrenia: Synergistic, Not Separate. Biol Psychiatry. 2020;87(3):204\u201314.","journal-title":"Biol Psychiatry"},{"key":"8177_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.schres.2024.09.011","volume":"274","author":"Q Su","year":"2024","unstructured":"Su Q, Xuekelaiti Z, Ma H, Qiu Y, Sun X, Bi F, Li M, Li J. The associations between duration of untreated psychosis, growth factors, and neurocognition in patients with drug-na\u00efve schizophrenia. Schizophr Res. 2024;274:113\u201320.","journal-title":"Schizophr Res"},{"issue":"4","key":"8177_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00406-021-01359-4","volume":"272","author":"M Li","year":"2022","unstructured":"Li M, Qiu Y, Zhang J, Zhang Y, Liu Y, Zhao Y, Jia Q, Fan X, Li J. Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia. Eur Arch Psychiatry Clin NeuroSci. 2022;272(4):633\u201342.","journal-title":"Eur Arch Psychiatry Clin NeuroSci"},{"key":"8177_CR12","doi-asserted-by":"crossref","unstructured":"Llorca-Bof\u00ed V, Parellada E, Mor\u00e9n C, Sellgren CM, Bioque M. Neuroinflammation: an unfortunate term to describe schizophrenia. Mol Psychiatry 2026.","DOI":"10.1038\/s41380-026-03450-5"},{"key":"8177_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbi.2024.07.041","volume":"122","author":"V Llorca-Bof\u00ed","year":"2024","unstructured":"Llorca-Bof\u00ed V, Petersen LV, Mortensen PB, Benros ME. White blood cell counts, ratios, and C-reactive protein among individuals with schizophrenia spectrum disorder and associations with long-term outcomes: a population-based study. Brain Behav Immun. 2024;122:18\u201326.","journal-title":"Brain Behav Immun"},{"key":"8177_CR14","doi-asserted-by":"crossref","unstructured":"Barron H, Hafizi S, Andreazza AC, Mizrahi R. Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk. Int J Mol Sci 2017, 18(3).","DOI":"10.3390\/ijms18030651"},{"key":"8177_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.lfs.2017.06.002","volume":"182","author":"JN Mazon","year":"2017","unstructured":"Mazon JN, de Mello AH, Ferreira GK, Rezin GT. The impact of obesity on neurodegenerative diseases. Life Sci. 2017;182:22\u20138.","journal-title":"Life Sci"},{"key":"8177_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.abb.2015.03.014","volume":"576","author":"TT Huang","year":"2015","unstructured":"Huang TT, Leu D, Zou Y. Oxidative stress and redox regulation on hippocampal-dependent cognitive functions. Arch Biochem Biophys. 2015;576:2\u20137.","journal-title":"Arch Biochem Biophys"},{"key":"8177_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejmech.2015.04.040","volume":"97","author":"AM Pisoschi","year":"2015","unstructured":"Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: A review. Eur J Med Chem. 2015;97:55\u201374.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"8177_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12888-020-02635-8","volume":"20","author":"Z Lu","year":"2020","unstructured":"Lu Z, Wen T, Wang Y, Kan W, Xun G. Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study. BMC Psychiatry. 2020;20(1):241.","journal-title":"BMC Psychiatry"},{"key":"8177_CR19","doi-asserted-by":"crossref","unstructured":"Cho KH, Nam HS, Kang DJ, Zee S, Park MH. Enhancement of High-Density Lipoprotein (HDL) Quantity and Quality by Regular and Habitual Exercise in Middle-Aged Women with Improvements in Lipid and Apolipoprotein Profiles: Larger Particle Size and Higher Antioxidant Ability of HDL. Int J Mol Sci 2023, 24(2).","DOI":"10.3390\/ijms24021151"},{"issue":"1","key":"8177_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0920-9964(98)00030-9","volume":"32","author":"JK Yao","year":"1998","unstructured":"Yao JK, Reddy R, McElhinny LG, van Kammen DP. Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophr Res. 1998;32(1):1\u20138.","journal-title":"Schizophr Res"},{"issue":"7","key":"8177_CR21","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1089\/ars.2010.3603","volume":"15","author":"JK Yao","year":"2011","unstructured":"Yao JK, Keshavan MS. Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal. 2011;15(7):2011\u201335.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"8177_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1620\/tjem.246.51","volume":"246","author":"L Wang","year":"2018","unstructured":"Wang L, Wang F, Liu J, Zhang Q, Lei P. Inverse Relationship between Baseline Serum Albumin Levels and Risk of Mild Cognitive Impairment in Elderly: A Seven-Year Retrospective Cohort Study. Tohoku J Exp Med. 2018;246(1):51\u20137.","journal-title":"Tohoku J Exp Med"},{"issue":"10","key":"8177_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1017\/S1355617714000885","volume":"20","author":"GE Crichton","year":"2014","unstructured":"Crichton GE, Elias MF, Davey A, Sullivan KJ, Robbins MA. Higher HDL cholesterol is associated with better cognitive function: the Maine-Syracuse study. J Int Neuropsychological Society: JINS. 2014;20(10):961\u201370.","journal-title":"J Int Neuropsychological Society: JINS"},{"issue":"12","key":"8177_CR24","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s00702-018-1935-8","volume":"125","author":"X Li","year":"2018","unstructured":"Li X, Jia S, Zhou Z, Jin Y, Zhang X, Hou C, Zheng W, Rong P, Jiao J. Effect of serum uric acid on cognition in patients with idiopathic REM sleep behavior disorder. J neural transmission (Vienna Austria: 1996). 2018;125(12):1805\u201312.","journal-title":"J neural transmission (Vienna Austria: 1996)"},{"issue":"2","key":"8177_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261\u201376.","journal-title":"Schizophr Bull"},{"key":"8177_CR26","doi-asserted-by":"crossref","unstructured":"Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ 3rd, Gold JM, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165(2):203\u201313.","DOI":"10.1176\/appi.ajp.2007.07010042"},{"issue":"1\u20133","key":"8177_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.schres.2015.09.003","volume":"169","author":"C Shi","year":"2015","unstructured":"Shi C, Kang L, Yao S, Ma Y, Li T, Liang Y, Cheng Z, Xu Y, Shi J, Xu X, et al. The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China. Schizophr Res. 2015;169(1\u20133):109\u201315.","journal-title":"Schizophr Res"},{"key":"8177_CR28","doi-asserted-by":"crossref","unstructured":"Sanllorente A, Lassale C, Soria-Florido MT, Casta\u00f1er O, Fit\u00f3 M, Hern\u00e1ez \u00c1. Modification of High-Density Lipoprotein Functions by Diet and Other Lifestyle Changes: A Systematic Review of Randomized Controlled Trials. J Clin Med 2021, 10(24).","DOI":"10.3390\/jcm10245897"},{"issue":"1","key":"8177_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ekir.2016.09.004","volume":"2","author":"S Sarwar","year":"2017","unstructured":"Sarwar S, Sherman RA. How Well Does Serum Albumin Correlate With Dietary Protein Intake in Dialysis Patients? Kidney Int Rep. 2017;2(1):90\u20133.","journal-title":"Kidney Int Rep"},{"key":"8177_CR30","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2147\/NDT.S424694","volume":"19","author":"X Zhu","year":"2023","unstructured":"Zhu X, Wen M, He Y, Feng J, Xu X, Liu J. The Relationship Between Level of Education, Cognitive Function and Medication Adherence in Patients with Schizophrenia. Neuropsychiatr Dis Treat. 2023;19:2439\u201350.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"19","key":"8177_CR31","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1056\/NEJMc1311765","volume":"369","author":"JT Kielstein","year":"2013","unstructured":"Kielstein JT. Glucose levels and risk of dementia. N Engl J Med. 2013;369(19):1863.","journal-title":"N Engl J Med"},{"issue":"5","key":"8177_CR32","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00406-023-01650-6","volume":"274","author":"M Li","year":"2024","unstructured":"Li M, Luo G, Qiu Y, Zhang X, Sun X, Li Y, Zhao Y, Sun W, Yang S, Li J. Negative symptoms and neurocognition in drug-na\u00efve schizophrenia: moderating role of plasma neutrophil gelatinase-associated lipocalin (NGAL) and interferon-gamma (INF-\u03b3). Eur Arch Psychiatry Clin NeuroSci. 2024;274(5):1071\u201381.","journal-title":"Eur Arch Psychiatry Clin NeuroSci"},{"key":"8177_CR33","doi-asserted-by":"publisher","first-page":"910814","DOI":"10.3389\/fpsyt.2022.910814","volume":"13","author":"G Liu","year":"2022","unstructured":"Liu G, Zhang X, Huo X, Li W. Prevalence, Influencing Factors, and Clinical Characteristics of Cognitive Impairment in Elderly Patients With Schizophrenia. Front Psychiatry. 2022;13:910814.","journal-title":"Front Psychiatry"},{"issue":"3","key":"8177_CR34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.dsx.2015.04.004","volume":"9","author":"A Wysoki\u0144ski","year":"2015","unstructured":"Wysoki\u0144ski A, Strzelecki D, K\u0142oszewska I. Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder. Diabetes metabolic syndrome. 2015;9(3):168\u201376.","journal-title":"Diabetes metabolic syndrome"},{"key":"8177_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.schres.2017.10.042","volume":"197","author":"PB Gjerde","year":"2018","unstructured":"Gjerde PB, Dieset I, Simonsen C, Hoseth EZ, Iversen T, Lagerberg TV, Lyngstad SH, M\u00f8rch RH, Skrede S, Andreassen OA, et al. Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis. Schizophr Res. 2018;197:253\u201360.","journal-title":"Schizophr Res"},{"issue":"6","key":"8177_CR36","first-page":"619","volume":"63","author":"MM Mielke","year":"2008","unstructured":"Mielke MM, Xue QL, Zhou J, Chaves PH, Fried LP, Carlson MC. Baseline serum cholesterol is selectively associated with motor speed and not rates of cognitive decline: the Women\u2019s Health and Aging Study II. journals Gerontol Ser Biol Sci Med Sci. 2008;63(6):619\u201324.","journal-title":"journals Gerontol Ser Biol Sci Med Sci"},{"issue":"3","key":"8177_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1532-5415.2010.02739.x","volume":"58","author":"CA Reynolds","year":"2010","unstructured":"Reynolds CA, Gatz M, Prince JA, Berg S, Pedersen NL. Serum lipid levels and cognitive change in late life. J Am Geriatr Soc. 2010;58(3):501\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"8177_CR38","doi-asserted-by":"crossref","unstructured":"Hottman DA, Chernick D, Cheng S, Wang Z, Li L. HDL and cognition in neurodegenerative disorders. Neurobiology of disease 2014, 72 Pt A:22\u201336.","DOI":"10.1016\/j.nbd.2014.07.015"},{"key":"8177_CR39","doi-asserted-by":"crossref","unstructured":"Marsillach J, Cervellati C. Paraoxonase-1 and Other HDL Accessory Proteins in Neurological Diseases. Antioxid (Basel Switzerland) 2021, 10(3).","DOI":"10.3390\/antiox10030454"},{"key":"8177_CR40","doi-asserted-by":"crossref","unstructured":"Chernick D, Zhong R, Li L. The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer\u2019s Disease. Biomolecules 2020, 10(9).","DOI":"10.3390\/biom10091276"},{"issue":"2","key":"8177_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X","volume":"48","author":"AM Fagan","year":"2000","unstructured":"Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG, Holtzman DM. Differences in the Abeta40\/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Ann Neurol. 2000;48(2):201\u201310.","journal-title":"Ann Neurol"},{"issue":"2\u20133","key":"8177_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0165-1781(00)00230-4","volume":"97","author":"JK Yao","year":"2000","unstructured":"Yao JK, Reddy R, van Kammen DP. Abnormal age-related changes of plasma antioxidant proteins in schizophrenia. Psychiatry Res. 2000;97(2\u20133):137\u201351.","journal-title":"Psychiatry Res"},{"issue":"1","key":"8177_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/JAD-160565","volume":"56","author":"M Boada","year":"2017","unstructured":"Boada M, Anaya F, Ortiz P, Olazar\u00e1n J, Shua-Haim JR, Obisesan TO, Hern\u00e1ndez I, Mu\u00f1oz J, Buendia M, Alegret M, et al. Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-\u03b2 Concentrations and Cognition Outcomes in Alzheimer\u2019s Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial. J Alzheimer\u2019s disease: JAD. 2017;56(1):129\u201343.","journal-title":"J Alzheimer\u2019s disease: JAD"},{"key":"8177_CR44","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3389\/fnins.2020.00859","volume":"14","author":"X Zhong","year":"2020","unstructured":"Zhong X, Liao Y, Chen X, Mai N, Ouyang C, Chen B, Zhang M, Peng Q, Liang W, Zhang W, et al. Abnormal Serum Bilirubin\/Albumin Concentrations in Dementia Patients With A\u03b2 Deposition and the Benefit of Intravenous Albumin Infusion for Alzheimer\u2019s Disease Treatment. Front NeuroSci. 2020;14:859.","journal-title":"Front NeuroSci"},{"issue":"1","key":"8177_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13195-020-00746-8","volume":"13","author":"Q Su","year":"2021","unstructured":"Su Q, Li T, He PF, Lu XC, Yu Q, Gao QC, Wang ZJ, Wu MN, Yang D, Qi JS. Trichostatin A ameliorates Alzheimer\u2019s disease-related pathology and cognitive deficits by increasing albumin expression and A\u03b2 clearance in APP\/PS1 mice. Alzheimers Res Ther. 2021;13(1):7.","journal-title":"Alzheimers Res Ther"},{"issue":"13","key":"8177_CR46","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","volume":"582","author":"M Roche","year":"2008","unstructured":"Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783\u20137.","journal-title":"FEBS Lett"},{"key":"8177_CR47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fncel.2020.00090","volume":"14","author":"A Armada-Moreira","year":"2020","unstructured":"Armada-Moreira A, Gomes JI, Pina CC, Savchak OK, Gon\u00e7alves-Ribeiro J, Rei N, Pinto S, Morais TP, Martins RS, Ribeiro FF, et al. Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases. Front Cell Neurosci. 2020;14:90.","journal-title":"Front Cell Neurosci"},{"key":"8177_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ntt.2012.07.007","volume":"36","author":"SS Moy","year":"2013","unstructured":"Moy SS, Nonneman RJ, Shafer GO, Nikolova VD, Riddick NV, Agster KL, Baker LK, Knapp DJ. Disruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL\/6J mice. Neurotoxicol Teratol. 2013;36:36\u201346.","journal-title":"Neurotoxicol Teratol"},{"key":"8177_CR49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12883-016-0564-9","volume":"16","author":"SM LeVine","year":"2016","unstructured":"LeVine SM. Albumin and multiple sclerosis. BMC Neurol. 2016;16:47.","journal-title":"BMC Neurol"},{"issue":"8","key":"8177_CR50","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1016\/S0021-9258(19)69552-9","volume":"256","author":"RK Kutty","year":"1981","unstructured":"Kutty RK, Maines MD. Purification and characterization of biliverdin reductase from rat liver. J Biol Chem. 1981;256(8):3956\u201362.","journal-title":"J Biol Chem"},{"issue":"1","key":"8177_CR51","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/s41598-018-38227-6","volume":"9","author":"XL Yin","year":"2019","unstructured":"Yin XL, Jia QF, Zhang GY, Zhang JP, Shirao T, Jiang CX, Yin XY, Liu YS, Chen P, Gu XC, et al. Association between decreased serum TBIL concentration and immediate memory impairment in schizophrenia patients. Sci Rep. 2019;9(1):1622.","journal-title":"Sci Rep"},{"issue":"7","key":"8177_CR52","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.tjnut.2023.05.014","volume":"153","author":"L Song","year":"2023","unstructured":"Song L, Li H, Fu X, Cen M, Wu J. Association of the Oxidative Balance Score and Cognitive Function and the Mediating Role of Oxidative Stress: Evidence from the National Health and Nutrition Examination Survey (NHANES) 2011\u20132014. J Nutr. 2023;153(7):1974\u201383.","journal-title":"J Nutr"},{"issue":"10","key":"8177_CR54","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2013.155","volume":"70","author":"RS Kahn","year":"2013","unstructured":"Kahn RS, Keefe RS. Schizophrenia is a cognitive illness: time for a change in focus. JAMA psychiatry. 2013;70(10):1107\u201312.","journal-title":"JAMA psychiatry"},{"issue":"3","key":"8177_CR55","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148\u201360.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"8177_CR56","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1600-0447.1993.tb03395.x","volume":"87","author":"S Nanko","year":"1993","unstructured":"Nanko S, Moridaira J. Reproductive rates in schizophrenic outpatients. Acta psychiatrica Scandinavica. 1993;87(6):400\u20134.","journal-title":"Acta psychiatrica Scandinavica"},{"issue":"6","key":"8177_CR57","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s12603-022-1813-9","volume":"26","author":"W Ni","year":"2022","unstructured":"Ni W, Liu W, Zhao Z, Yuan X, Sun Y, Zhang H, Wang L, Zhou M, Yin P, Xu J. Body Mass Index and Mortality in Chinese Older Adults -New Evidence from a Large Prospective Cohort in China. J Nutr Health Aging. 2022;26(6):628\u201336.","journal-title":"J Nutr Health Aging"},{"key":"8177_CR58","doi-asserted-by":"publisher","first-page":"638773","DOI":"10.3389\/fpsyt.2021.638773","volume":"12","author":"XJ Peng","year":"2021","unstructured":"Peng XJ, Hei GR, Yang Y, Liu CC, Xiao JM, Long YJ, Huang J, Zhao JP, Wu RR. The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Na\u00efve Patients With Schizophrenia. Front Psychiatry. 2021;12:638773.","journal-title":"Front Psychiatry"},{"issue":"1\u20133","key":"8177_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.schres.2014.04.039","volume":"157","author":"A McCleery","year":"2014","unstructured":"McCleery A, Ventura J, Kern RS, Subotnik KL, Gretchen-Doorly D, Green MF, Hellemann GS, Nuechterlein KH. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment. Schizophr Res. 2014;157(1\u20133):33\u20139.","journal-title":"Schizophr Res"},{"issue":"3","key":"8177_CR60","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/npr2.12445","volume":"44","author":"M Alrouji","year":"2024","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alshammari MS, Alexiou A, Papadakis M, Bahaa MM, Batiha GE. Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective. Neuropsychopharmacol Rep. 2024;44(3):639\u201349.","journal-title":"Neuropsychopharmacol Rep"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08177-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08177-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08177-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:01:42Z","timestamp":1786687302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08177-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8177"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08177-9","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors confirm that all procedures performed in this study comply with the ethical standards of the relevant national and institutional committees on human experimentation, as well as the ethical principles of the Declaration of Helsinki (1975, as revised in 2008). The study was approved by the Tianjin Anding Hospital Medical Ethics Committee (Approval Number: 2017-03), and written informed consent was obtained from all participants prior to their enrollment in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"629"}}